Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution
M. Azoulay(McGill University Health Centre), Bassam Abdulkarim(University of Alberta), Ayman Oweida(Université de Sherbrooke), Valérie Panet-Raymond(McGill University Health Centre), Fabiano Santos(Universidade do Estado do Rio de Janeiro), Scott Owen(McGill University Health Centre), George Shenouda(McGill University Health Centre), Kevin Petrecca(McGill University Health Centre), Marie Christine Guiot(Montreal Neurological Institute and Hospital), Luís Souhami(McGill University Health Centre)
Cited by 83
Related Papers
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k